EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis

European Respiratory Journal

Volumn 37, Issue 1, 2011, Pages 18-25

  Lee, J ^a,b   Nordestgaard, B G ^a,b   Dahl, M ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Chronic obstructive pulmonary disease; Genetics; Lung function; Meta analysis; Microsomal epoxide hydrolase; Tobacco smoking

Indexed keywords

ANTIASTHMATIC AGENT; EPOXIDE HYDROLASE;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SMOKING; SPIROMETRY;

ASTHMA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; EPOXIDE HYDROLASES; FORCED EXPIRATORY VOLUME; GENETIC VARIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 79251545773     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00012110     Document Type: Article

References (42)

1. DeMeo DL, Hersh CP, Hoffman EA, et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007; 176: 42-48.
2. Brøgger J, Steen VM, Eiken HG, et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006; 27: 682-688.
3. Lokke A, Lange P, Scharling H, et al. Developing COPD: a 25-year follow up study of the general population. Thorax 2006; 61: 935-939. (Pubitemid 44787161)
4. Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998; 157: 1770-1778.
5. Foreman MG, DeMeo DL, Hersh CP, et al. Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J 2007; 30: 1124-1130.
6. Tomaki M, Sugiura H, Koarai A, et al. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007; 20: 596-605.
7. Chappell S, Daly L, Morgan K, et al. Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J 2008; 32: 931-937.
8. Hassett C, Aicher L, Sidhu JS, et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3: 421-428.
9. Schnohr P, Jensen JS, Scharling H, et al. Coronary heart disease risk factors ranked by importance for the individual and community. A 21-year follow-up of 12,000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002; 23: 620-626.
10. Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
11. Dahl M, Bowler RP, Juul K, et al. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008; 178: 906-912.
12. Yang X, Liang SH, Weyant DM, et al. The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. J Pharmacol Exp Ther 2009; 330: 23-30.
13. Siedlinski M, Postma DS, Smit HA, et al. No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population. Eur Respir J 2009; 33: 446-449.
14. Park SS, Kim EJ, Son CY, et al. Genetic polymorphism of epoxide hydrolase and GSTM1 in chronic obstructive pulmonary disease. Tuberc Respir Dis 2003; 55: 88-97.
15. Yim JJ, Park GY, Lee CT, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121-125.
16. Takeyabu K, Yamaguchi E, Suzuki I, et al. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J 2000; 15: 891-894.
17. Xiao D, Wang C, Du MJ, et al. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin Med J (Engl) 2004; 117: 661-667.
18. Rodriguez F, Jardi R, Costa X, et al. Detection of polymorphisms at exons 3 (Tyr113 - >.His) and 4 (His139 - >.Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem 2002; 308: 120-126.
19. Budhi A, Hiyama K, Isobe T, et al. Genetic susceptibility for emphysematous changes of the lung in Japanese. Int J Mol Med 2003; 11: 321-329.
20. Korytina GF, Yanbaeva DG, Viktorova TV. Polymorphisms of the cytochrome P450 (CYP1A1, CYP2E1) and microsomal epoxide hydrolase (mEPHX) genes in cystic fibrosis and chronic respiratory disease. Mol Biol 2003; 37: 663-670.
21. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630-633.
22. Matheson MC, Raven J, Walters EH, et al. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol 2006; 78: 705-717.
23. Vibhuti A, Arif E, Deepak D, et al. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun 2007; 359: 136-142.
24. Zidzik J, Slaba E, Joppa P, et al. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J 2008; 49: 182-191.
25. Park JY, Chen L, Wadhwa N, et al. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med 2005; 15: 443-448.
26. Cheng SL, Yu CJ, Chen CJ, et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23: 818-824.
27. Fu WP, Sun C, Dai LM, et al. Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population. Oncol Rep 2007; 17: 483-488.
28. Hersh CP, DeMeo DL, Lange C et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78.
29. Keicho N, Emi M, Kajita M, et al. Overestimated frequency of a possible emphysema-susceptibility allele when microsomal epoxide hydrolase is genotyped by the conventional polymerase chain reaction-based method. J Hum Genet 2001; 46: 96-98.
30. Juul K, Tybjaerg-Hansen A, Marklund S, et al. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 858-864.
31. Dahl M, Tybjaerg-Hansen A, Lange P, et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in a1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 2002; 136: 270-279.
32. Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, et al. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. Am J Respir Crit Care Med 2010; 181: 17-20.
33. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163: 469-473.
34. Yoshikawa M, Hiyama K, Ishioka S, et al. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 2000; 5: 49-53.
35. Hersh CP, DeMeo DL, Lazarus R, et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 977-984.
36. Hu G, Shi Z, Hu J, et al. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses. Respirology 2008; 13: 837-850.
37. Smolonska J, Wijmenga C, Postma DS, et al. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 2009; 180: 618-631.
38. Polonikov AV, Ivanov VP, Solodilova MA. Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility. J Hum Genet 2009; 54: 440-449.
39. Moffatt MF. Genes in asthma: new genes and new ways. Curr Opin Allergy Clin Immunol 2008; 8: 411-417.
40. Salam MT, Lin PC, Avol EL, et al. Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax 2007; 62: 1050-1057.
41. Duan S, Huang RS, Zhang W, et al. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 2008; 82: 1101-1113.
42. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448: 470-473.